Emerging role of glioma stem cells in mechanisms of therapy resistance

F Eckerdt, LC Platanias - Cancers, 2023 - mdpi.com
Simple Summary Glioblastoma is among the most lethal cancers in humans. Glioblastomas
exhibit a striking heterogeneity, which is maintained by a highly plastic, adaptable …

Targeting CSC-related transcription factors by E3 ubiquitin ligases for cancer therapy

W Wang, W Liu, Q Chen, Y Yuan, P Wang - Seminars in Cancer Biology, 2022 - Elsevier
Evidence has revealed that transcription factors play essential roles in regulation of multiple
cellular processes, including cell proliferation, metastasis, EMT, cancer stem cells and …

Implantable Microneedle‐Mediated Eradication of Postoperative Tumor Foci Mitigates Glioblastoma Relapse

Y Zhang, Z Fang, Z Liu, K Xi, Y Zhang… - Advanced …, 2024 - Wiley Online Library
Glioblastoma multiforme (GBM) remains incurable despite multimodal treatments after
surgical debulking. Almost all patients with GBM relapse within a narrow margin (2–3 cm) of …

Clinical applications of immunotherapy for recurrent glioblastoma in adults

MM Olivet, MC Brown, ZJ Reitman, DM Ashley… - Cancers, 2023 - mdpi.com
Simple Summary There are few established treatment options for recurrent glioblastoma
(rGBM). Immunotherapy, which potentiates the immune system to counter tumor growth …

[HTML][HTML] Interaction of tumor-associated microglia/macrophages and cancer stem cells in glioma

X Zhu, Y Fang, Y Chen, Y Chen, W Hong, W Wei, J Tu - Life Sciences, 2023 - Elsevier
Glioma is the most common tumor of the primary central nervous system, and its malignant
phenotype has been shown to be closely related to glioma stem cells (GSCs). Although …

Local delivery of doxorubicin prodrug via lipid nanocapsule–based hydrogel for the treatment of glioblastoma

M Wang, R Bergès, A Malfanti, V Préat… - Drug delivery and …, 2024 - Springer
Glioblastoma (GBM) recurrences appear in most cases around the resection cavity borders
and arise from residual GBM cells that cannot be removed by surgery. Here, we propose a …

TSPO PET signal using [18F]GE180 is associated with survival in recurrent gliomas

S Quach, A Holzgreve, L Kaiser, M Unterrainer… - European Journal of …, 2023 - Springer
Purpose Glioma patients, especially recurrent glioma, suffer from a poor prognosis. While
advances to classify glioma on a molecular level improved prognostication at initial …

A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups

P Karschnia, M Smits, G Reifenberger… - The Lancet …, 2023 - thelancet.com
Surgical resection represents the standard of care for people with newly diagnosed diffuse
gliomas, and the neuropathological and molecular profile of the resected tissue guides …

Unraveling the intricacies of glioblastoma progression and recurrence: insights into the role of NFYB and oxidative phosphorylation at the single-cell level

P Liu, N Xing, Z Xiahou, J Yan, Z Lin… - Frontiers in …, 2024 - frontiersin.org
Background Glioblastoma (GBM), with its high recurrence and mortality rates, makes it the
deadliest neurological malignancy. Oxidative phosphorylation is a highly active cellular …

Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions

J Liu, R Piranlioglu, F Ye, K Shu, T Lei… - Frontiers in Cellular …, 2023 - frontiersin.org
Glioblastoma is a highly aggressive form of brain cancer characterized by the abundance of
myeloid lineage cells in the tumor microenvironment. Tumor-associated macrophages and …